SeQure Dx (Series A)
Funding Details
Awarder
Inbox
Date Award
August 3, 2021
Vertical
Genomics
Funding Amount
$17,500,000
Company Info
Founders
Ellen Sheets, MD, MBA
Market
Gene Therapy
Location
Waltham, MA, USA
Coinvestors
Alexandria Venture Investments, Bold Capital, Casdin Capital, Digitalis Ventures, KdT Ventures, Mass General Brigham Ventures, RiverVest Venture Partners
Company Description

SeQure Dx provides safety data for on and off-target CRISPR gene editing therapies